List of Excipients in API metronidazole oral
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing metronidazole oral
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Saptalis Pharmaceuticals LLC | LIKMEZ | metronidazole oral | 71656-066 | CELLULOSE, MICROCRYSTALLINE | |
| Saptalis Pharmaceuticals LLC | LIKMEZ | metronidazole oral | 71656-066 | GLYCERIN | |
| Saptalis Pharmaceuticals LLC | LIKMEZ | metronidazole oral | 71656-066 | MAGNESIUM ALUMINUM SILICATE | |
| Saptalis Pharmaceuticals LLC | LIKMEZ | metronidazole oral | 71656-066 | METHYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for metronidazole oral
Excipient focus: CELLULOSE, MICROCRYSTALLINE
metronidazole oral drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
metronidazole oral drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM ALUMINUM SILICATE
metronidazole oral drug variants containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
metronidazole oral drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT
metronidazole oral drug variants containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
metronidazole oral drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE
metronidazole oral drug variants containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
metronidazole oral drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STRAWBERRY
metronidazole oral drug variants containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
metronidazole oral drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
metronidazole oral drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
metronidazole oral drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | metronidazole oral | 71656-066 |
| Kesin Pharma Corporation | metronidazole oral | 81033-066 |
| >Company | >Ingredient | >NDC |
metronidazole oral drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch